🇺🇸 AMGN — Amgen Inc.

Salud Mantener
← Volver

Precio actual

461,26 USD

Máx. histórico

466,01

4 días

Split 2:1 del 22/11/1999

Caída desde máximo

-1,02%

Rango 52 semanas

294,48 – 475,65

Variación hoy

-0,90%

Cierre anterior

465,45

Rango de hoy

460,15 – 467,02

Volumen hoy

2.351.852

Peor caída histórica

-78,03%

17/06/1983 → 19/11/1984

Recuperado en 487 días

Volatilidad anualizada ⓘ

37,45%

Información
Nombre completo
Amgen Inc.
Divisa
USD
Mercado
NasdaqGS
Sector
Salud
Industria
Drug Manufacturers - General
Empleados
31.500
PER ⓘ
28,65 (puede no estar actualizado)
Dividend yield
2,17% (puede no estar actualizado)
Precio objetivo analistas
397,32 USD (puede no estar actualizado)
Primera cotización
17/06/1983
Precio actualizado
hace 14 horas
Sobre la empresa

Amgen Inc. discovers, develops, manufactures, and delivers human therapeutics worldwide. The company's principal products include Enbrel for the treatment of rheumatoid arthritis, plaque psoriasis, and psoriatic arthritis; Otezla for the treatment of adult patients with plaque psoriasis, psoriatic arthritis, and oral ulcers associated with Behçet's disease; Prolia to treat postmenopausal women with osteoporosis; XGEVA for skeletal-related events prevention; Repatha, which reduces the risks of myocardial infarction, stroke, and coronary revascularization; Nplate for the treatment of patients with immune thrombocytopenia; KYPROLIS to treat patients with relapsed or refractory multiple myeloma; Aranesp to treat a lower-than-normal number of red blood cells and anemia; EVENITY for the treatment of osteoporosis in postmenopausal for women; Vectibix to treat patients with wild-type RAS metastatic colorectal cancer; BLINCYTO for the treatment of patients with acute lymphoblastic leukemia; TEPEZZA to treat thyroid eye disease; and KRYSTEXXA for the treatment of chronic refractory gout. It also markets other products, including PROLIA, REPATHA, OTEZLA, ENBREL, EVENITY, XGEVA, TEPEZZA, BLINCYTO, NPLATE, TEZSPIRE, KYPROLIS, ARANESP, KRYSTEXXA AND VECTIBIX, MVASI, PAVBLU, UPLIZNA, IMDELLTRA/IMDYLLTRA, AMJEVITA/AMGEVITA, TAVNEOS, NEULASTA, LUMAKRAS/LUMYKRAS, RAVICTI, PARSABIV, AIMOVIG, WEZLANA/WEZENLA, AND PROCYSBI. The company serves healthcare providers, including physicians or their clinics, dialysis centers, hospitals, and pharmacies. It distributes its products through pharmaceutical wholesale distributors. The company has collaboration agreements with AstraZeneca plc for the development and commercialization of TEZSPIRE; BEONE MEDICINES LTD. to develop and commercialize Aimovig; UCB for the development and commercialization of EVENITY; Kyowa Kirin Co., Ltd. for rocatinlimab development and commercialization; and BeiGene, Ltd. for oncology products expansion and development. The company was incorporated in 1980 and is headquartered in Thousand Oaks, California.

Dividendos repartidos Total últimos 12 meses: 9,9400 USD · Yield: 2,15%
Fecha de pago Importe por participación
21/08/2026 2,5200 USD
15/05/2026 2,5200 USD
13/02/2026 2,5200 USD
21/11/2025 2,3800 USD
22/08/2025 2,3800 USD
16/05/2025 2,3800 USD
14/02/2025 2,3800 USD
18/11/2024 2,2500 USD
16/08/2024 2,2500 USD
16/05/2024 2,2500 USD
15/02/2024 2,2500 USD
16/11/2023 2,1300 USD
17/08/2023 2,1300 USD
17/05/2023 2,1300 USD
14/02/2023 2,1300 USD
Splits Registrados en el histórico de precios
Fecha Ratio
22/11/1999 2:1
01/03/1999 2:1
16/08/1995 2:1
11/09/1991 3:1
13/08/1990 2:1
Rentabilidad mensual
Evolución
Histórico día a día
Fecha Apertura Máximo Mínimo Cierre Variación Volatilidad día Volumen
16/05/2023 234,21 234,51 227,74 227,88 -2,42% 2,89% 2.646.500
15/05/2023 233,27 233,92 232,12 233,53 +0,25% 0,77% 1.551.300
12/05/2023 233,03 233,55 231,21 232,95 +0,28% 1,00% 1.295.600
11/05/2023 234,65 234,99 230,41 232,29 -0,78% 1,95% 1.612.400
10/05/2023 234,89 235,00 231,35 234,11 -0,14% 1,55% 1.530.800
09/05/2023 234,64 235,44 233,22 234,43 -0,08% 0,95% 1.468.900
08/05/2023 235,34 235,74 232,20 234,62 -0,81% 1,50% 1.667.800
05/05/2023 232,66 237,04 232,07 236,53 +2,00% 2,14% 2.806.800
04/05/2023 230,31 232,03 229,15 231,89 +1,13% 1,25% 2.228.500
03/05/2023 235,97 236,30 228,98 229,31 -2,82% 3,10% 2.998.000
02/05/2023 238,08 239,00 235,39 235,97 -1,23% 1,52% 2.127.200
01/05/2023 240,03 241,30 238,09 238,90 -0,35% 1,34% 1.920.500
28/04/2023 236,82 240,10 233,17 239,74 -0,25% 2,93% 2.721.400
27/04/2023 239,24 240,71 235,40 240,34 +0,64% 2,22% 2.533.900
26/04/2023 242,08 243,55 238,58 238,80 -2,48% 2,05% 2.002.900
25/04/2023 245,12 246,53 244,31 244,87 +0,17% 0,91% 1.509.700
24/04/2023 243,20 245,37 242,33 244,45 +0,24% 1,25% 1.232.100
21/04/2023 243,46 243,92 242,65 243,86 +0,16% 0,52% 1.721.300
20/04/2023 246,12 246,40 243,05 243,46 -1,12% 1,36% 1.691.300
19/04/2023 245,25 246,76 244,37 246,21 +0,05% 0,97% 1.246.500
18/04/2023 248,37 249,01 244,65 246,09 -0,80% 1,76% 1.638.800
17/04/2023 250,89 251,50 247,58 248,07 -0,77% 1,56% 1.784.800
14/04/2023 250,62 251,76 248,96 250,00 -0,57% 1,12% 1.866.200
13/04/2023 248,60 251,90 248,27 251,44 +0,78% 1,46% 2.020.900
12/04/2023 252,50 252,71 248,88 249,50 -0,77% 1,52% 2.268.900
11/04/2023 251,42 253,08 250,98 251,43 +0,21% 0,84% 1.272.800
10/04/2023 256,44 256,44 250,05 250,90 -0,96% 2,49% 1.595.600
06/04/2023 254,36 255,43 252,93 253,32 -0,02% 0,98% 2.047.800
05/04/2023 248,57 253,71 248,23 253,37 +2,36% 2,20% 2.468.000
04/04/2023 244,52 248,11 243,80 247,53 +1,26% 1,76% 2.942.800